Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 212Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective
Pamela Andanda,Jane Wathuta
Medicine, Health Care and Philosophy.2018;21(1)139
2Availability of post-trial access in clinical trials: a review of clinical trial protocols submitted to the research ethics board of the University of the Philippines Manila
Edlyn B. Jimenez,Jessa Mae P. Virtudazo,Cristina E. Torres,Rosemarie dlC Bernabe
Current Medical Research and Opinion.2019;35(11)1849
3Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management
J. Lawton,M. Blackburn,D. Rankin,C. Werner,C. Farrington,R. Hovorka,N. Hallowell
AJOB Empirical Bioethics.2019;10(2)100
4An entertainment-education approach to prevent COVID-19 spread: study protocol for a multi-site randomized controlled trial
Alain Vandormael,Maya Adam,Merlin Greuel,Till Bärnighausen
5An entertainment-education approach to prevent COVID-19 spread: study protocol for a multi-site randomized controlled trial
Isha Lingayat,Pranali Mishra,Nupur Vasdev,Suryanarayana Polaka,Ankit Mishra,Rakesh Kumar Tekade
6Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations’ Websites
Haruka Nakada,Kyoko Takashima
Clinical Pharmacology in Drug Development.2019;8(8)978
7Participant Engagement and Reactance to a Short, Animated Video About Added Sugars: Web-based Randomized Controlled Trial
Caterina Favaretti,Alain Vandormael,Violetta Hachaturyan,Merlin Greuel,Jennifer Gates,Till Bärnighausen,Maya Adam
JMIR Public Health and Surveillance.2022;8(1)e29669
8Perspective sur la responsabilité de l’industrie pharmaceutique dans la promotion de la recherche pédiatrique et dans l’accès aux médicaments essentiels
Neyla Dahane,Béatrice Godard
Global Health Promotion.2021;28(3)78
9Ethics of post-trial access to treatment in dermatology
Sarah Nasser,Abraham M. Korman,Stephanie K. Fabbro
Journal of the American Academy of Dermatology.2022;86(2)498

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal